Store

Home | Store | 2023 Oncology in Diagnostic Imaging Market Outlook Report
brand-logo

2023 Oncology in Diagnostic Imaging Market Outlook Report

Publication Date: August 6, 2025

SKU: 23-064

Tags: Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), Mammography, Nuclear Medicine, Oncology and Cancer, PET/CT, Ultrasound, X-ray

Pages: 117

SKU: 23-064

IMV’s 2023 Oncology in Diagnostic Imaging Market Outlook Report explores oncology-related imaging market factors across CT, MRI, PET, SPECT, C-Arm, Mammography, X-Ray and Ultrasound systems. The report examines aspects of market trends, procedure volume, installed base, equipment purchase plans, contrast utilization/budgets, trends, and site operations characteristics. Survey results are projected to the identified universe of oncology-related imaging facilities, and the report provides budget and purchase plans for oncology-related imaging systems for 2023-2026.

Respondents participated in an IMV-hosted online survey from July 5 to October 25, 2023.

▪Key topics include:

  • Departments Priorities & Outlook for Oncology-related imaging
  • Installed Base of equipment used in oncology-related imaging
  • Procedure Volumes
  • Benchmark Hospital Site Performance
  • Trends related to oncology-related imaging
  • Purchase Plans
  • Demographics & Site Operations

This report is ideal for anyone interested in learning more about how advancements in oncology-related imaging are impacting the medical diagnostic imaging market. It is a great resource for:

  • Healthcare Administrators
  • Physicians
  • Marketing Managers
  • Product Managers
  • Marketing Directors
  • Sales Managers
  • Analysts

That work in oncology-related diagnostic imaging equipment manufacturing, hospital and healthcare systems, consulting, investment and finance industries. This report is a great way to get a quick overview of recent developments and help to plan for what lies ahead.

IMV 2023 ONCOLOGY IN DIAGNOSTIC IMAGING MARKET OUTLOOK REPORT

 

Exhibits

 

  1. Priorities & Outlook……………………………………………………………………………………………………… 13

 

  1. Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 14

  1. Priorities to the Mission of Imaging Departments, with Regard to Oncology-Related Imaging,

by Hospital Bed Size, as of 2023 Survey………………………………………………………………………………………………………. 15

  1. Hospitals vs. Non-Hospitals: Priorities to the Mission of Imaging Departments,

with Regard to Oncology-Related Imaging, as of 2023 Survey…………………………………………………………………….. 16

  1. 2023 Department Outlook for Oncology-Related Procedure Volume, Reimbursement Levels, Revenue,

And Net Income, Compared to 2022…………………………………………………………………………………………………………….. 18

  1. 2023 Imaging Department Outlook for Oncology-Related Patients by Site Type, Compared to 2022…………. 19
  2. 2023 Imaging Department Outlook for Oncology-Related Procedures by Site Type, Compared to 2022…….. 19
  3. 2023 Imaging Department Outlook for Oncology-Related Reimbursement per patient by Site Type,

Compared to 2022…………………………………………………………………………………………………………………………………………. 19

  1. 2023 Imaging Department Outlook for Oncology-Related Revenue by Site Type, Compared to 2022………… 19
  2. 2023 Imaging Department Outlook for Oncology-Related Net Income/Profits by Site Type,

Compared to 2022…………………………………………………………………………………………………………………………………………. 19

 

  1. Installed Base……………………………………………………………………………………………………………… 20

 

  1. Imaging Equipment Used for Oncology-Related Imaging Procedures, as of 2023 Survey…………………………… 21
  2. Imaging Equipment Used for Oncology-Related Imaging Procedures, by Hospital vs. Non-Hospital

, as of 2023 Survey………………………………………………………………………………………………………………………………………… 22

  1. Imaging Equipment Used for Oncology-Related Imaging Procedures, by Hospital Bed Size,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 23

  1. Imaging Equipment Used for Oncology-Related Imaging Procedures, by Hospital Ownership Type,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 24

  1. Distribution of Sites, by Number of Imaging Systems Used for Oncology-Related Imaging,

by Modality, by Hospital Bed Size, as of 2023 Survey…………………………………………………………………………………. 25

  1. Average Units per Site Used for Oncology-Related Imaging Procedures, by Equipment Type,

by Site Type, as of 2023 Survey……………………………………………………………………………………………………………………. 26

  1. Imaging Equipment Manufacturers Used for Oncology-Related Imaging, All Modalities,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 27

  1. Imaging Equipment Manufacturers Used for Oncology-Related Imaging, All Modalities,

by Site Type, as of 2023 Survey……………………………………………………………………………………………………………………. 28

  1. Imaging Equipment Manufacturers Used for Oncology-Related Imaging Procedures, by Modality,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 29

  1. Contrast Media Power Injector Manufacturers Used for Oncology-Related Imaging Procedures,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 30

 

C… Procedure Volumes……………………………………………………………………………………………………… 31

 

  1. Oncology-Related Procedures per Site, by Modality, by Hospital vs. Non-Hospital……………………………………. 32
  2. Whether 2024 Oncology-Related Procedures are Anticipated to Increase, Stay the Same,

or Decrease Compared to 2023, by Modality, as of 2023 Survey…………………………………………………………………. 33

  1. Average Oncology-Related Imaging Procedures per Site, 2022 vs. 2023, by Modality……………………………….. 34
  2. Mix of Hospital Screening vs. Diagnostic Oncology Imaging Procedures, by Modality, 2023…………………….. 35
  3. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures by Modality, 2023…. 36
  4. Mix of Adult vs. Pediatric Oncology Imaging Procedures, by Modality, 2023…………………………………………….. 37
  5. Average Oncology-Related Procedures Using CT per Site, 2022 vs. 2023, by Site Type…………………………….. 38
  6. Whether 2024 Oncology-Related Procedures Using CT are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 39

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using CT,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 40

  1. Average Oncology-Related Procedures Using MR per Site, 2022 vs. 2023, by Site Type……………………………. 41
  2. Whether 2024 Oncology-Related Procedures Using MR are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 42

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using MR,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 43

  1. Average Oncology-Related Procedures Using PET per Site, 2022 vs. 2023, by Site Type…………………………… 44
  2. Whether 2024 Oncology-Related Procedures Using PET are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 45

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using PET,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 46

  1. Average Oncology-Related Procedures Using SPECT per Site, 2022 vs. 2023, by Site Type……………………… 47
  2. Whether 2024 Oncology-Related Procedures Using SPECT are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 48

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using SPECT,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 49

  1. Average Oncology-Related Procedures Using C-Arm per Site, 2022 vs. 2023, by Site Type………………………. 50
  2. Whether 2024 Oncology-Related Procedures Using C-Arm are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 51

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using C-Arm,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 52

  1. Average Oncology-Related Procedures Using Mammography per Site, 2022 vs. 2023, by Site Type…………. 53
  2. Whether 2024 Oncology-Related Procedures Using Mammography are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 54

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using Mammography,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 55

  1. Average Oncology-Related Procedures Using X-Ray per Site, 2022 vs. 2023, by Site Type……………………….. 56
  2. Whether 2024 Oncology-Related Procedures Using X-Ray are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 57

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using X-Ray,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 58

  1. Average Oncology-Related Procedures Using Ultrasound per Site, 2022 vs. 2023, by Site Type………………… 59
  2. Whether 2024 Oncology-Related Procedures Using Ultrasound are Anticipated to Increase,

Stay the Same, or Decreased Compared to 2023, by Modality, as of 2023 Survey………………………………………. 60

  1. Mix of Hospital Inpatient, Outpatient, and Emergency Oncology Imaging Procedures Using Ultrasound,

by Hospital Bed Size, 2023……………………………………………………………………………………………………………………………. 61

  1. Contrast Usage in Oncology-Related CT and MRI Imaging Procedures, 2023…………………………………………….. 62
  2. Percent of Oncology Imaging Procedures Performed on Obese Patients, by Modality, 2023……………………….. 63
  3. Primary Reasons for Anticipated Increase in Oncology-Related Imaging Procedures in 2024,

by Modality, as of 2023 Survey…………………………………………………………………………………………………………………….. 64

  1. Imaging Modalities Most Frequently Used in Oncology-Related Imaging Exams, by Cancer Type,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 65

  1. Primary Sources of Referrals for Oncology-Related Imaging Exams, as of 2023 Survey…………………………….. 66
  2. Ranking of Primary Sources of Referrals for Oncology-Related Imaging Exams, as of 2023 Survey………….. 67
  3. Top 3 Ranking for Sources Referring Patients for Oncology-Related Imaging, by Site Type,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 68

D.   Purchase Plans……………………………………………………………………………………………………………. 69

 

  1. Percent of Sites Planning to Purchase Imaging Equipment for Use in Oncology-Related Imaging Procedures,

from 2023 through 2026, by Modality, by Hospital vs. Non-Hospital, as of 2023 Survey……………………………. 70

  1. Percent of Sites Planning to Purchase Imaging Equipment for Use in Oncology-Related Imaging Procedures,

from 2023 through 2026, by Modality, by Hospitals Bed Size, as of 2023 Survey………………………………………. 71

  1. Distribution of Planning to Purchase Imaging Equipment for Use in Oncology-Related Imaging

Procedures, by Number of Units Planned, by Modality, as of 2022 Survey………………………………………………….. 72

  1. Budget Status for Planned Imaging Equipment Purchases, by Modality, as of 2023 Survey………………………… 73
  2. Plans to Purchase New vs. Refurbished/Used Units, by Modality, as of 2023 Survey………………………………….. 74
  3. Plans to Purchase Additional vs. Replacement Units, by Modality, as of 2023 Modality…………………………….. 75
  4. Average Age of Oldest Unit Being Replaced, by Modality, as of 2023 Survey……………………………………………. 76
  5. Manufacturers Considered for Next Imaging Equipment Purchase, as of 2023 Survey………………………………… 77
  6. Distribution of 2023 Equipment Budgets to be used on Oncology-Related Imaging Equipment………………….. 78
  7. Distribution of Anticipated 2023-2026 Oncology-Related Imaging Equipment Budgets, as of 2023 Survey. 79
  8. Distribution of 2023 Oncology-Related Imaging Equipment Budgets by Site type………………………………………. 80

 

  1. Trends……………………………………………………………………………………………………………………… 81

 

  1. Factors Affecting the Future Outlook for Oncology-Related Imaging at Your Facility,

Over the Next Few Years, as of 2023 Survey ………………………………………………………………………………………………. 82

  1. Hospitals vs. Non-Hospitals: Factors Affecting the Future Outlook for Oncology-Related Imaging

at Your Facility Over the Next Few Years, as of 2023 Survey……………………………………………………………………… 83

  1. Factors Affecting the Future Outlook for Oncology-Related Imaging at Your Facility Over the Next

Few Years, by Hospital Bed Size, as of 2023 Survey……………………………………………………………………………………. 84

  1. Current Use and Consideration of Artificial Intelligence, with Oncology-Related Imaging Procedures,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 85

  1. Current Use and Consideration of Artificial Intelligence, with Oncology-Related Imaging Procedures,

by Site Type, as of 2023 Survey……………………………………………………………………………………………………………………. 86

  1. Primary Reasons Oncology Patients are Referred to the Imaging Department, as of 2023 Survey………………. 87
  2. #1/#2 Ranking Reasons Patients are Referred to the Imaging Department, by Site Type,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 88

  1. Types of Physicians Receiving Oncology-Related Imaging Scans and Related Information,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 89

  1. #1/#2 Ranked Types of Physicians Receiving Oncology-Related Imaging Scans and Related Information,

by Site Type, as of 2023 Survey……………………………………………………………………………………………………………………. 90

  1. Primary Methods of Sharing Oncology-Related Images and Patient Information with Physicians,

as of 2023 Survey………………………………………………………………………………………………………………………………………….. 91

  1. #1/#2 Ranking for Primary Methods of Sharing Onclogy-Related Images and Patient Information

with Physicians, by Site Type, as of 2023 Survey…………………………………………………………………………………………. 92

  1. Whether Facility Participates in Tumor Conferences, as of 2023 Survey……………………………………………………… 93
  2. Whether Facility Participates in Tumor Conferences, by Site Type, Compared to 2022………………………………. 93
  3. Physician Specialties Represented in Tumor Conferences, as of 2023 Survey……………………………………………… 94
  4. Physician Specialties Represented in Tumor Conferences, by Site Type as of 2023 Survey………………………… 95
  5. Summary of Open-Ended Responses for Current 2023 Use of AI in Oncology-Related Imaging………………… 96
  6. Summary of Open-Ended Responses for Future 2024 Use of AI in Oncology-Related Imaging………………….. 97
  7. Summary of Open-Ended Suggestions for Oncology-Related Product Capabilities……………………………………… 98

F.   Demographics & Site Operations……………………………………………………………………………………. 99

 

  1. Hospital vs. Non-Hospital Mix of Sites Performing Oncology-Related Imaging, with Bed Size Mix of

Hospital Locations, as of 2023 Survey………………………………………………………………………………………………………… 100

  1. Location Type by Site Type, as of 2023 Survey………………………………………………………………………………………….. 101
  2. Ownership of Non-Hospital Imaging Facilities, as of 2023 Survey……………………………………………………………. 101
  3. Academic/University Hospital Status, as a Percentage of Hospital Sites, by Bed Size, as of 2023 Survey… 102
  4. Hospital Ownership Type, as a Percentage of Hospitals Sites, by Bed Size, as of 2023 Survey…………………. 102
  5. Whether Patients are Scheduled Within Imaging Department or by Central Scheduling Department,

as of 2023 Survey………………………………………………………………………………………………………………………………………… 103

  1. Whether Patients are Scheduled Within Imaging Department or by Central Scheduling Department,

By Site Type, Compared to 2022………………………………………………………………………………………………………………… 103

  1. Typical Waiting Time for Scheduled Imaging Appointment, by Modality, as of 2023 Survey………………….. 104
  2. Typical Waiting Time for Scheduled Imaging Appointment, by Modality and Site Type,

as of 2023 Survey………………………………………………………………………………………………………………………………………… 105

 

G.   Appendix…………………………………………………………………………………………………………………… 106

 

  1. Imaging Equipment Used for Oncology-Related Imaging Procedures, by Site Type, as of 2023 Survey…… 107
  2. Distribution of Sites, by Number of Imaging Systems Used for Oncology-Related Imaging, by Modality,

by Hospital Bed Size, as of 2023 Survey…………………………………………………………………………………………………….. 108

  1. Manufacturers Considered for Next Imaging Equipment Purchase, by Modality, as of 2023 Survey………… 109
  2. Current 2023 Uses of AI in Oncology-Related Imaging – Open-Ended Responses……………………………………. 110
  3. Future 2024 Uses of AI in Oncology-Related Imaging – Open-Ended Responses……………………………………… 112
  4. Suggestions for Oncology-Related Product Capabilities –

Open-Ended Responses……………………………………………………………………………………………………………………………….. 114

  1. About IMV………………………………………………………………………………………………………………………………………………….. 117

 

 

Our Knowledge Center provides access to

all market reports

Click here
to learn more

Related products

brand-logo

Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

November 29, 2023

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

Price range: $5,000.00 through $7,500.00

brand-logo

Histology and Cytology IVD Market Update, 2024

May 21, 2024

Histology and cytology have long been essential components of pathological laboratories, offering critical insights into cells, tissues, and organs. Through histopathological examinations, a variety of diseases, including cancer, can be accurately diagnosed. Physicians rely heavily on pathological information to determine treatment plans and prognoses.

Histology and Cytology IVD Market Update, 2024 provides an in-depth competitive analysis…

Price range: $5,000.00 through $7,875.00

brand-logo

The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition

March 7, 2024

Explore the cutting-edge world of molecular point-of-care (mPOC) diagnostic solutions with our latest report, offering a detailed analysis of the market and future growth potential from 2023-2028. mPOC technology revolutionizes diagnostic capabilities, providing enhanced sensitivity and specificity compared to traditional near-patient tests. These solutions are instrumental in critical care units, physician offices, outpatient clinics,…

Price range: $5,000.00 through $7,875.00

IVD Market Trends Report, March 2023

Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…

Price range: $3,000.00 through $4,500.00

IVD Market Trends Report, March 2023

Cell and Gene Therapy Deals Analysis, 2021-2024

Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…

Price range: $6,300.00 through $9,450.00

Cell and Gene Therapy Deals Analysis, 2021-2024

Cell Therapy and Gene Therapy Disease Markets, 2023-2029

Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…

Price range: $5,000.00 through $7,875.00

Cell Therapy and Gene Therapy Disease Markets, 2023-2029